medigraphic.com
ISSN 0138-7103 (Print)

2021, Number 3

<< Back Next >>

Revista del Hospital Psiquiátrico de La Habana 2021; 18 (3)

Neurocognitive deficits in patients with oncologic disease

da Silva RCY, Carvalho FPA

Language: Spanish
References: 40
Page:
PDF size: 291.37 Kb.


ABSTRACT

Introduction: Neurocognitive deficits in oncological patients can arise from brain tumors; from malignant tumors that metastatize to the CNS, which are mainly those of the lung, breast, gastrointestinal melanoma, colorectal and other unidentified ones, which are considered the most frequent among the world population, and from the neurotoxic effects of the therapies used against cancer.
Objective: To describe the neurocognitive deficits in patients with oncologic disease reported in the literature.
Methods: Articles, books, manuals and specialized papers of scientific production were reviewed in the databases and directories: EBSCOhost, Scopus, Springer Protocols, Springer Journals, BioOne, Cambridge Journals Collection, Elsevier Science Direct, Wiley Online Library, Nature, Emerald, Google Bocks, Google Scholar, PubMed, Dialnet, SciELO, DOAJ, Latindex and REDIB, using descriptors in English, Portuguese and Spanish.
Development: Through the qualitative data analysis program ATLAS.ti, version 9, it was possible to carry out a classification by category family for neurocognitive deficit and oncological disease. In this respect, the subcategories attention and executive functions, perception, memory and learning, and language were reviewed, based on primary and secondary tumors, and sequelae of the therapeutic intervention. The relational networks obtained from this process made it possible to codify, organize and identify cross-references of the concepts, as well as the carrying out of this literature review.
Conclusions: Neurocognitive deficit can arise as a consequence of the oncological disease at all levels, the main concern being the impact of the deficit on the patient’s autonomy and quality of life.


REFERENCES

  1. Da Silva CYR. Neuropsicología de la Enfermedad Oncológica. México: Amazon; 2021.

  2. El-Metwally TH. Cancer Biology: An Updated Global Overview. Nueva York: Nova Science Publishers, Inc.; 2009.

  3. Farreras RC, Cordellach F. Compendio de Medicina Interna. 6.ª ed. Madrid: Elsevier; 2017.

  4. Noggle CA, Dean RS. The Neuropsychology of Cancer and Oncology. Nueva York: Springer Publishing Company; 2013.

  5. Shin KY. Cancer. Nueva York, NY: Demos Medical; 2014.

  6. Knowles MA, Selby P. Introduction to the Cellular and Molecular Biology of Cancer. Nueva York: OUP Oxford; 2005.

  7. Germanno BD. Cancer Clusters. Nueva York: Nova Science Publishers, Inc.; 2011.

  8. Keating P, Cambrosio A. Cancer on Trial: Oncology as a New Style of Practice. Chicago: University of Chicago Press; 2012.

  9. Ruddon RW. Cancer Biology. 4.ª ed. Oxford: Oxford University Press; 2007.

  10. Da Silva CYR. Neuropsicología del Envejecimiento. México: Manual Moderno; 2018.

  11. Hernández R, Fernández C, Del Pilar M. Metodologia de la Investigación. 6.ª ed. México: McGraw Hill; 2014.

  12. Glaser B., Strauss A. The Discovery of Grounded Theory: strategies for qualitative research. Chicago: Aldine; 1967.

  13. Strauss AL, Corbin JM. Basics of qualitative research: Grounded theory procedures and technique. 2.ª ed. Newbury Park, CA: SAGE Publications, Inc.; 1990.

  14. Saldaña J. The Coding Manual for Qualitative Researchers. Thousand Oaks, CA: Sage Publications, Inc.; 2009.

  15. Ali JS, Andrasik F, Berlin KS, Porter J, Hankins J, Anderson S, et al. Attention difficulties are associated with lower engagement in adult care amongst youth with sickle cell disease. British Journal of Haematology. 2020;189:1-30. DOI: 10.1111/bjh.16421

  16. Desjardins L, Solomon A, Janzen L, Bartels U, Schulte F, Chung J, et al. Executive functions a social skills in pediatric brain tumor survivors. Applied Neuropsychology: Child. 2020;9:83–91. DOI: 10.1080/21622965.2018.1522589

  17. Diamond A. Executive functions. Annual Review of Psychology. 2013;64:135–68. DOI: 10.1146/annurev-psych-113011-143750

  18. Meskal I, Gehring K, Rutten GJM, Sitskoorn MM. Cognitive functioning in meningioma patients: a systematic review. Journal of Neuro-Oncology. 2016;128:195-205. DOI: 10.1007/s11060-016-2115-z

  19. Wager M, Boisgueheneuc FD, Pluchon C, Bouyer C, Stal V, Bataille B, et al. Intraoperative Monitoring of an Aspect of Executive Functions: Administration of the Stroop Test in 9 Adult Patients During Awake Surgery for Resection of Frontal Glioma. Operative Neurosurgery. 2013;72(2):169-81. DOI: 10.1227/NEU.0b013e31827bf1d6

  20. Bury M, Borkowska AR, Daniluk B. Impact of chemotherapy on memory, attention and executive functions depending on the stages of treatment and the level of depression in female patients with cancer. Acta Neuropsychologica. 2014;12(4):417-27. DOI: 10.5604/17307503.1138845

  21. Remes TM, Hovén E, Ritari N, Pohjasniemi H, Puosi R, Arikoski PM, et al. Neurocognitive impairment, employment, and social status in radiotherapy-treated adult survivors of childhood brain tumors. Neuro-Oncology Practice. 2021;8(3):266–77. DOI: 10.1093/nop/npab004

  22. Decker SL, Carboni JA, Englund JA. Assessing visual-spatial and construction skills in a pediatric population. In A. S. Davis (Ed.). Handbook of pediatric neuropsychology. New York, NY: Springer Publishing Company; 2011. p. 309–18.

  23. Lee BH, Kang E, Cho SS, Kin E, Seo SW, Kim G, Lee KH, Na DL. Neural correlates of hemispatial neglect: A voxel-based SPECT Study. Cerebrovascular Disease. 2010;30:573–83. DOI: 10.1159/000319770

  24. Verdon V, Schwartz S, Lovblad KO, Hauert CA, Vuilleumier P. Neuroanatomy of hemispatial neglect and its functional components: A study using voxel-based lesion-symptom mapping. Brain. 2010;133(3):880–94. DOI: 10.1093/brain/awp305

  25. Monjea M, Dietrichb J. Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behavioural Brain Research. 2012;277(2):376-9. DOI: 10.1016/j.bbr.2011.05.012

  26. Kargiotis O, Markoula S, Kyritsis AP. Epilepsy in the cancer patient. Cancer Chemotherapy and Pharmacology. 2011;67(3):489–501. DOI: 10.1007/s00280-011-1569-0

  27. Monje M, Dietrich J. Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behavioural Brain Research. 2012;227(2):376–9. DOI: 10.1016/j.bbr.2011.05.012

  28. Omuro A, Taillandier L, Chinot O, Sierra Del Rio M, Carnin C, Barrie M, et al. Primary CNS lymphoma in patients younger than 60: Can whole-brain radiotherapy be deferred? Journal of Neuro-oncology. 2011;104(1):323–30. DOI: 10.1007/s11060-010-0497-x

  29. Thomasa D, Marie-Odileb B, Isabellec L, Hervéd T, Georgese N, Dimitrif P, et al. Cognitive outcome after radiotherapy in brain tumor, Current Opinion in Oncology. 2015;27(6):510-5. DOI: 10.1097/CCO.0000000000000227

  30. Yim W, Yetisgen M, Harris WP, Kwan SW. Natural Language Processing in Oncology: A Review. JAMA Oncol. 2016;2(6):797–804. DOI: 10.1001/jamaoncol.2016.0213

  31. Ah DV, Habermann B, Carpenter JS, Schneider BL. Impact of perceived cognitive impairment in breast cancer survivors. European Journal of Oncology Nursing. 2013;17(2): 236-41. DOI: 10.1016/j.ejon.2012.06.002

  32. Santini B, Talacchi A, Squintani G, Casagrande F, Capasso R, Miceli G. Cognitive outcome after awake surgery for tumors in language areas. Journal of Neuro-Oncology. 2012;108(2):319-26. DOI: 10.1007/s11060-012-0817-4

  33. Noll KR, Sullaway C, Ziu M, Weinberg JS, Wefel JS. Relationships between tumor grade and neurocognitive functioning in patients with glioma of the left temporal lobe prior to surgical resection. Neuro-Oncology. 2015;17(4):580–587. DOI: 10.1093/neuonc/nou233

  34. Harvey PD. Domains of cognition and their assessment. Dialogues Clinical Neuroscience. 2019;21:227-37. DOI: 10.31887/DCNS.2019.21.3/pharvey

  35. Vardy JL, Dhillon HM, Pond GR, Rourke SB, Bekele T, Renton C, et al. Cognitive Function in Patients with Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study. Journal of Clinical Oncology. 2015;33(34):4085-92. DOI: 10.1200/JCO.2015.63.0905

  36. Talacchi A, Santini B, Savazzi S. Cognitive effects of tumour ang surgical treatment in glioma patients. Journal of Neuro-Oncology. 2011;103:541-9. DOI: 10.1007/s11060-010-0417-0

  37. Gupta P, Vu TA, Lamoureux EL. Beyond Visual Acuity — A Comprehensive Assessment of Vision and Cognition in Older Adults with Visual Impairment. JAMA Netw Open. 2021;4(7):e2119033. DOI: 10.1001/jamanetworkopen.2021.19033

  38. Kessel E, Baumfalk AE, Zandvoort MJE Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment. Journal of Neuro-Oncology. 2017;134:9–18. DOI: 10.1007/s11060-017-2503-z

  39. Pendergrass JC, Targum SD, Harrison JE. Cognitive impairment associated with cancer: A brief review. Innovations in Clinical Neuroscience. 2018;15(1-2):36–44. PMCID: PMC5819720

  40. Antonsson M, Longoni F, Jakola A. Pre-operative language ability in patients with presumed low-grade glioma. Journal of Neuro-oncology. 2018;137:93–102. DOI: 10.1007/s11060-017-2699-y




2020     |     www.medigraphic.com